FDA Drug Recalls
457 recalls, newest first
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 10, 2026
Reason Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Class II · Moderate risk Ongoing Jun 10, 2026
Reason Lack of assurance of Sterility:
Class II · Moderate risk Ongoing Jun 8, 2026
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing Jun 8, 2026
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing Jun 8, 2026
Reason Subpotent Drug
Class II · Moderate risk Ongoing Jun 7, 2026
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Ongoing Jun 5, 2026
Reason Failed Dissolution Specifications
Class II · Moderate risk Ongoing Jun 4, 2026
Reason Presence of Foreign Substance
Class II · Moderate risk Ongoing Jun 4, 2026
Reason sub potency
Class II · Moderate risk Ongoing Jun 4, 2026
Reason Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Class II · Moderate risk Ongoing Jun 4, 2026
Reason CGMP Deviations
Class II · Moderate risk Ongoing Jun 4, 2026
Reason Presence of Foreign Substance.
Class II · Moderate risk Ongoing Jun 4, 2026
Reason CGMP Deviations
Class II · Moderate risk Ongoing Jun 4, 2026
Reason CGMP Deviations
Class II · Moderate risk Ongoing Jun 4, 2026
Reason Presence of Foreign Substance.
Class I · High risk Ongoing Jun 4, 2026
Reason Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.
Class II · Moderate risk Ongoing Jun 4, 2026
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Class II · Moderate risk Ongoing Jun 4, 2026
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Class III · Low risk Ongoing Jun 3, 2026
Reason Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.